Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 3—March 2008


Ciprofloxacin-Resistant Salmonella enterica Serotype Typhimurium, China

Shenghui Cui*, Jingyun Li*, Ziyong Sun†, Changqin Hu*, Shaohong Jin*, Yunchang Guo‡, Lu Ran‡, and Yue Ma*Comments to Author 
Author affiliations: *State Food and Drug Administration, Beijing, People’s Republic of China; †Huazhong University of Science and Technology, Wuhan, People’s Republic of China; ‡Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China;

Main Article


Resistance phenotypes of Salmonella enterica serotype Typhimurium
 isolated from Tongji Hospital outpatients, Wuhan, China, May 2002–October 2005

Antimicrobial agent MIC, μg/mL* No. resistant isolates
(n = 44)
Phenicols (chloramphenicol) >32 33
Ampicillin >32 35
Amoxicillin–clavulanic acid >32/16 32
Cefepime >32 0
Cefotaxime >64 0
Ceftriaxone >64 0
Tetracyclines (tetracycline) >16 36
Amikacin >64 2
Gentamicin >16 35
Kanamycin >64 15
Streptomycin† NA 40
Sulfonamides and potentiated sulfonamides
Sulfamethoxazole >512 39
Trimethoprim-sulfamethoxazole >4/76 36
Quinolones and fluoroquinolones
Nalidixic acid >32 36
Ciprofloxacin >4 31

*MICs were determined by the broth-microdilution method; results were interpreted in accordance with the interpretive standards of the Clinical and Laboratory Standards Institute (4).
†Resistance to streptomycin was determined by disk-diffusion method. NA, not applied.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO